Sally Hargreaves, Laura B Nellums, Sofanne J Ravensbergen, Jon S Friedland, Ymkje Stienstra and on behalf of the ESGITM Working Group on Vaccination in Migrants

Background Migrants within the European Union and European Economic Area (EU/EEA) may be underimmunised and lack documentation on previous vaccinations. We investigated approaches to vaccination in recently arrived adult and child migrants, and guideline availability and implementation. Methods: Between March and May 2017, a national vaccination expert from every EU/EEA country and Switzerland completed an electronic questionnaire. We used descriptive analyses to calculate percentages, and framework analysis to synthesise free-text responses. Results: We approached 32 countries (response rate 100%). Although 28 experts reported vaccination guidance at national level, specific guidelines for recently arrived migrants were only available in six countries and not consistently implemented. Twenty-three countries administered vaccinations during on-arrival health checks. Most experts recommended multiple vaccination opportunities be made available: at point of entry (n = 13) or at holding level (reception centres, migrant camps, detention centres) (n = 21). In 30 countries, child migrants without evidence of previous vaccination were re-vaccinated according to the national schedule. Diphtheria-pertussis-tetanus and polio vaccinations were given to migrant children in all countries, measles-mumps-rubella (MMR) in 31 countries, hepatitis B vaccination in 25. Low levels of catch-up vaccination were reported in adult migrants, with only 13 countries offering MMR and 10 countries charging fees. Conclusion: Existing guidance is often not migrant-specific and may not be applied in practice; clarification is needed on which vaccines should be given. Strategies are needed specifically for catch-up vaccination in adult migrants. Vaccinations should be offered in multiple settings, free of charge, with sufficient guidance and training provided to front-line healthcare professionals.

ProMED Mail

Hepatitis -- China1. Eyngor, M., Zamostiano, R., Kembou Tsofack, J. E., Berkowitz, A., Bercovier, H., Tinman, S., Lev, M., Huryitz, A., Galeotti, M., and Eldar, A. (2014). Identification of a novel RNA virus lethal to tilapia. Journal of Clinical Microbiology, 52 (12), 4137-4146, .2. Dong, H.T., Siriroob, S., Meemetta, W., Santimanawong, W., Gangnonngiw, W., Pirarat, N., Khunrae, K., Rattanarojpong, T., Vanichviriyakit, R., and Senapin, S. (2017a). Emergence of tilapia lake virus in Thailand and an …